Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| BCC | BOISE CASCADE CO | $3.18B | 37,337,473 | 47.85% | 52.15% | Net Selling | Net Selling | ||
| CHE | CHEMED CORP | $6.44B | 14,571,695 | 94.84% | 4.09% | Net Selling | Net Selling | ||
| DT | DYNATRACE INC | $14.66B | 301,506,242 | 63.87% | 36.13% | Net Selling | Net Selling | ||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.42B | 64,230,722 | 72.12% | 27.88% | Net Selling | Net Selling | ||
| SIBN | SI-BONE INC | $653.15M | 43,140,936 | 57.26% | 42.74% | Net Selling | Net Selling | ||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.40B | 140,215,198 | 46.10% | 53.90% | Net Selling | Net Buying | ||
| JBS | JBS NV | $17.56B | 1,109,058,185 | 6.98% | 0.00% | ||||
| SLP | SIMULATIONS PLUS INC | $295.47M | 20,127,110 | 61.56% | 38.44% | Net Selling | Net Selling | ||
| CYRX | CRYOPORT INC | $439.09M | 50,066,968 | 92.41% | 4.60% | Net Buying | Net Buying | ||
| SLDB | SOLID BIOSCIENCES INC | $427.50M | 77,869,071 | 55.70% | 44.30% | Net Buying | |||
| PCVX | VAXCYTE INC | $4.02B | 129,823,355 | 88.06% | 11.94% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $374.74M | 59,014,667 | 61.02% | 38.98% | Net Selling | |||
| RCUS | ARCUS BIOSCIENCES INC | $1.23B | 106,430,976 | 63.74% | 36.26% | Net Buying | Net Selling | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $266.60M | 74,262,990 | 25.94% | 74.06% | Net Buying | |||
| IIIV | I3 VERTICALS INC | $993.12M | 32,265,204 | 72.48% | 27.52% | Net Selling | Net Selling | ||
| CTMX | CYTOMX THERAPEUTICS INC | $160.44M | 80,621,293 | 85.98% | 14.02% | Net Selling | |||
| COP | CONOCOPHILLIPS | $115.31B | 1,248,942,311 | 82.37% | 0.44% | Net Selling | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $549.07M | 68,634,329 | 73.02% | 26.98% | Net Buying | |||
| ABOS | ACUMEN PHARMACEUTICALS INC | $76.32M | 60,573,425 | 62.08% | 17.23% | Net Selling | |||
| COGT | COGENT BIOSCIENCES INC | $1.73B | 139,700,796 | 89.41% | 10.59% | Net Buying | Net Buying | ||
| WYFI | WHITEFIBER INC | N/A | 34,856,250 | 0.00% | 77.78% | Net Buying | Net Buying | ||
| DSP | VIANT TECHNOLOGY INC | $585.45M | 62,951,133 | 13.39% | 86.61% | Net Selling | |||
| DNLI | DENALI THERAPEUTICS INC | $1.92B | 146,212,278 | 60.84% | 39.16% | Net Selling | Net Buying | ||
| ALMS | ALUMIS INC | $455.80M | 104,064,302 | 75.27% | 24.28% | Net Buying | |||
| DNTH | DIANTHUS THERAPEUTICS INC | $1.19B | 32,159,982 | 53.74% | 46.26% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $255.16M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| TRVI | TREVI THERAPEUTICS INC | $982.13M | 121,776,855 | 38.52% | 61.48% | Net Buying | |||
| EVEX | EVE HOLDING INC | $1.15B | 300,848,904 | 4.79% | 84.94% | ||||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.61B | 53,211,074 | 32.70% | 4.94% | Net Buying | |||
| KYTX | KYVERNA THERAPEUTICS INC | $169.09M | 43,245,667 | 50.86% | 49.14% | ||||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $140.28M | 53,955,085 | 33.61% | 64.87% | Net Buying | Net Buying | ||
| IVA | INVENTIVA SA | $507.97M | 95,662,391 | 5.15% | 0.00% | ||||
| HLLY | HOLLEY INC | $378.16M | 121,593,411 | 15.02% | 84.98% | Net Selling | Net Selling | ||
| MGX | METAGENOMI INC | $68.31M | 37,533,136 | 20.52% | 33.05% | Net Selling | |||
| VKTX | VIKING THERAPEUTICS INC | $2.71B | 112,444,961 | 67.75% | 8.98% | Net Selling | Net Selling | ||
| PRMB | PRIMO BRANDS CORP | $8.38B | 373,520,961 | 29.33% | 70.67% | Net Selling | Net Buying | ||
| ABCL | ABCELLERA BIOLOGICS INC | $1.30B | 298,484,664 | 36.06% | 44.65% | Net Buying | |||
| ATXS | ASTRIA THERAPEUTICS INC | $415.93M | 56,434,894 | 80.69% | 19.31% | ||||
| SI | SHOULDER INNOVATIONS INC | $304.18M | 20,359,960 | 0.00% | 58.21% | Net Buying | Net Buying | ||
| SPWH | SPORTSMAN's WAREHOUSE HOLDINGS INC | $117.60M | 38,431,079 | 39.64% | 60.36% | Net Buying | Net Buying | ||
| SW | SMURFIT WESTROCK PLC | $23.22B | 522,125,044 | 85.86% | 0.47% | Net Selling | |||
| IMRX | IMMUNEERING CORP | $285.47M | 36,318,877 | 10.54% | 38.57% | Net Buying | Net Buying | ||
| NUVL | NUVALENT INC | $5.72B | 72,104,837 | 75.08% | 24.92% | Net Selling | Net Buying | ||
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $16.50B | 256,287,081 | 77.50% | 22.50% | Net Buying | Net Buying | ||
| MBRX | MOLECULIN BIOTECH INC | $11.27M | 30,286,168 | 1.43% | 20.90% | Net Buying | Net Buying | ||
| SPIR | SPIRE GLOBAL INC | $320.63M | 32,583,984 | 28.28% | 71.72% | Net Selling | Net Selling | ||
| PHVS | PHARVARIS NV | $1.28B | 54,737,043 | 82.28% | 0.00% | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $29.38M | 68,003,613 | 21.00% | 15.70% | ||||
| VNRX | VOLITIONRX LTD | $67.79M | 107,595,421 | 22.29% | 35.52% | Net Buying | Net Buying | ||
| GPCR | STRUCTURE THERAPEUTICS INC | $1.16B | 172,793,818 | 31.63% | 12.59% | Net Selling | Net Selling | ||
| MNPR | MONOPAR THERAPEUTICS | $336.20M | 6,169,961 | 13.57% | 86.43% | Net Selling | Net Selling | ||
| DYN | DYNE THERAPEUTICS INC | $1.83B | 142,263,740 | 80.45% | 19.55% | Net Buying | Net Buying | ||
| ANIX | ANIXA BIOSCIENCES INC | $115.87M | 32,916,915 | 16.25% | 82.80% | Net Buying | Net Buying | ||
| ENOV | ENOVIS CORP | $1.85B | 57,159,803 | 42.73% | 57.27% | Net Selling | Net Buying | ||
| AVBP | ARRIVENT BIOPHARMA INC | $768.78M | 40,568,944 | 76.19% | 23.81% | Net Buying | Net Buying | ||
| SSTI | SOUNDTHINKING INC | $158.61M | 12,791,251 | 59.76% | 34.59% | Net Selling | Net Selling | ||
| ANGO | ANGIODYNAMICS INC | $426.66M | 40,633,885 | 78.99% | 21.01% | Net Selling | Net Selling | ||
| MVIS | MICROVISION INC | $284.16M | 249,261,553 | 33.57% | 11.83% | Net Selling | Net Selling | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.62B | 209,920,430 | 84.08% | 15.92% | Net Selling | Net Buying | ||
| BMEA | BIOMEA FUSION INC | $116.64M | 59,508,518 | 48.27% | 28.91% | Net Buying | |||
| RVMD | REVOLUTION MEDICINES INC | $8.64B | 186,933,190 | 90.56% | 9.44% | Net Buying | Net Buying | ||
| LXEO | LEXEO THERAPEUTICS INC | $290.53M | 54,001,214 | 78.28% | 13.27% | Net Buying | Net Selling | ||
| PAYO | PAYONEER GLOBAL INC | $2.33B | 360,315,543 | 77.46% | 22.54% | Net Selling | Net Selling | ||
| PTCT | PTC THERAPEUTICS INC | $4.67B | 79,257,019 | 84.83% | 15.17% | Net Selling | Net Selling | ||
| BEAM | BEAM THERAPEUTICS INC | $2.15B | 101,162,026 | 85.71% | 14.29% | Net Selling | Net Selling | ||
| SENS | SENSEONICS HOLDINGS INC | $368.24M | 814,680,910 | 18.61% | 26.32% | Net Selling | Net Buying | ||
| SION | SIONNA THERAPEUTICS INC | $984.76M | 44,139,823 | 63.96% | 36.04% | Net Buying | Net Selling | ||
| BRSL | BRIGHTSTAR LOTTERY | $3.39B | 201,858,765 | 49.75% | 0.00% | ||||
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $21.67B | 1,147,150,917 | 62.80% | 0.79% | Net Selling | Net Selling | ||
| GTN | GRAY MEDIA INC | $568.01M | 101,793,413 | 68.19% | 31.81% | Net Buying | Net Selling | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.10B | 59,235,547 | 49.48% | 50.52% | Net Selling | Net Selling | ||
| TNGX | TANGO THERAPEUTICS INC | $758.79M | 111,260,247 | 60.20% | 39.80% | Net Selling | Net Selling | ||
| TECX | TECTONIC THERAPEUTIC INC | $310.43M | 18,712,128 | 23.90% | 76.10% | Net Buying | Net Selling | ||
| GHRS | GH RESEARCH PLC | $813.19M | 62,028,145 | 70.22% | 0.00% | ||||
| MTVA | METAVIA INC | $36.30M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| GDS | GDS HOLDINGS LTD | $7.23B | 1,555,180,903 | 5.21% | 0.00% | ||||
| AARD | AARDVARK THERAPEUTICS INC | $215.88M | 21,696,893 | 41.09% | 47.02% | Net Buying | Net Buying | ||
| CABA | CABALETTA BIO INC | $96.92M | 50,743,101 | 94.52% | 5.48% | ||||
| NKTR | NEKTAR THERAPEUTICS | $608.07M | 12,406,968 | 23.75% | 76.25% | Net Selling | Net Selling | ||
| ICUI | ICU MEDICAL INC | $3.26B | 24,685,714 | 71.43% | 28.57% | Net Buying | Net Buying | ||
| WVE | WAVE LIFE SCIENCES LTD | $1.11B | 159,140,460 | 68.10% | 31.90% | Net Buying | Net Selling | ||
| WALD | WALDENCAST PLC | $214.71M | 122,692,968 | 18.93% | 0.00% | ||||
| GANX | GAIN THERAPEUTICS INC | $58.96M | 35,948,606 | 10.54% | 3.63% | ||||
| TRUP | TRUPANION INC | $1.91B | 42,783,675 | 64.56% | 35.44% | Net Selling | Net Selling | ||
| ALIT | ALIGHT INC | $1.94B | 539,288,631 | 75.67% | 24.33% | Net Selling | Net Selling | ||
| IRON | DISC MEDICINE INC | $2.08B | 34,765,581 | 56.99% | 43.01% | Net Selling | Net Selling | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $181.39M | 56,862,635 | 65.69% | 34.31% | Net Selling | Net Buying | ||
| VERI | VERITONE INC | $177.55M | 45,294,195 | 16.37% | 66.15% | Net Selling | Net Buying | ||
| IPSC | CENTURY THERAPEUTICS INC | $42.94M | 86,389,098 | 26.19% | 47.24% | Net Selling | Net Selling | ||
| SANA | SANA BIOTECHNOLOGY INC | $768.11M | 237,806,498 | 50.57% | 49.43% | Net Selling | |||
| MSTR | MICROSTRATEGY INC | $92.95B | 283,552,947 | 48.48% | 0.16% | Net Buying | Net Buying | ||
| IMUX | IMMUNIC INC | $74.07M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| PRQR | PROQR THERAPEUTICS NV | $213.81M | 107,710,916 | 37.56% | 0.00% | ||||
| ACRS | ACLARIS THERAPEUTICS INC | $199.24M | 108,281,239 | 58.78% | 41.22% | Net Buying | |||
| QNCX | QUINCE THERAPEUTICS INC | $85.94M | 53,713,798 | 14.11% | 76.73% | Net Buying | Net Buying | ||
| NRIX | NURIX THERAPEUTICS INC | $662.82M | 76,449,355 | 91.27% | 8.73% | Net Selling | Net Selling | ||
| BHVN | BIOHAVEN LTD | $1.45B | 105,788,197 | 81.99% | 18.01% | Net Buying | |||
| INUV | INUVO INC | $50.34M | 14,425,343 | 8.07% | 91.93% | Net Selling | Net Selling | ||
| AIRO | AIRO GROUP HOLDINGS INC | $553.91M | 27,421,095 | 13.11% | 43.69% | Net Selling | Net Selling | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $167.44M | 84,994,261 | 13.90% | 15.58% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.